AWM Investment Company’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-158,676
Closed -$554K 112
2023
Q2
$554K Hold
158,676
0.08% 100
2023
Q1
$611K Sell
158,676
-304,644
-66% -$1.11M 0.08% 101
2022
Q4
$1.3M Hold
463,320
0.19% 76
2022
Q3
$973K Hold
463,320
0.15% 91
2022
Q2
$1.21M Sell
463,320
-9,268
-2% -$31.1K 0.19% 89
2022
Q1
$2.06M Sell
472,588
-27,412
-5% -$108K 0.27% 83
2021
Q4
$2.15M Hold
500,000
0.22% 85
2021
Q3
$2.52M Hold
500,000
0.25% 85
2021
Q2
$3.08M Sell
500,000
-398,878
-44% -$2.96M 0.3% 77
2021
Q1
$6.58M Sell
898,878
-72,803
-7% -$621K 0.74% 46
2020
Q4
$7.9M Buy
971,681
+350,000
+56% +$2.7M 1% 36
2020
Q3
$4.91M Sell
621,681
-180,936
-23% -$1.24M 0.8% 47
2020
Q2
$4.37M Sell
802,617
-214,265
-21% -$1.06M 0.77% 45
2020
Q1
$4.17M Buy
1,016,882
+500,000
+97% +$2.92M 1.11% 31
2019
Q4
$3.72M Buy
516,882
+33,416
+7% +$206K 0.73% 48
2019
Q3
$3.06M Buy
483,466
+58,466
+14% +$373K 0.65% 50
2019
Q2
$3.36M Hold
425,000
0.64% 49
2019
Q1
$3.4M Hold
425,000
0.67% 49
2018
Q4
$2.6M Buy
+425,000
New +$2.61M 0.57% 55

Other funds holding ETON

AWM Investment Company's ETON Position: Q3 2023 in Review

AWM Investment Company sold out of Eton Pharmaceutcials (ETON) in Q3 2023, closing a stake of 158,676 shares — an estimated $554K sold.

AWM Investment Company first reported a position in ETON in Q4 2018 and held it in 19 quarters. The position peaked at $7.9M in Q4 2020. 50 funds tracked by Wall St. Rank hold ETON as of Q3 2023.

  • AWM Investment Company reported no remaining Eton Pharmaceutcials position as of Q3 2023 after selling out during the quarter.
  • AWM Investment Company sold 158,676 Eton Pharmaceutcials shares in Q3 2023, an estimated $554K.
  • AWM Investment Company first reported a position in Eton Pharmaceutcials in Q4 2018 and held it in 19 quarters.
  • AWM Investment Company's Eton Pharmaceutcials position peaked at $7.9M in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2023.

Based on AWM Investment Company's 13F filing for Q3 2023, filed 14 Nov 2023.